Cost Reductions Through Efficient Sales Activities and Optimized Personnel Allocation

「Selling, general and administrative expenses decreased by ¥13.578 million year on year, mainly because development expenses declined as a result of the completion of joint research, despite an increase in personnel expenses due to wage increases and other factors.」

「Against this backdrop, the Group worked vigorously to sell high-sensitivity comprehensive analysis services for metabolites, thereby seeking to expand orders in the Advanced Research and Development Support Business, while continuing to reduce general and administrative expenses excluding research and development expenses.」

「Against this backdrop, the Group worked vigorously to sell high-sensitivity comprehensive analysis services for metabolites, thereby seeking to expand orders in the Advanced Research and Development Support Business, while continuing to reduce general and administrative expenses excluding research and development expenses.」

「The Company also continued working to reduce general and administrative expenses excluding research and development expenses.」

「The Company achieved substantial cost reductions in selling, general and administrative expenses by promoting efficient sales activities, optimizing staff allocation and substantially reducing general and administrative expenses following the completion of procedures to close its European subsidiary, among other measures.」

「As a result of efforts to reduce selling, general and administrative expenses, operating income rose substantially to ¥268.874 million, up 174.9% year on year; ordinary income rose to ¥302.765 million, up 155.2%; and quarterly net income attributable to owners of the parent rose to ¥281.056 million, up 200.1%.」

「As a result of efforts to reduce selling, general and administrative expenses, operating income was ¥76.859 million, compared with operating income of ¥2.358 million in the same period of the previous year; ordinary income was ¥82.124 million, compared with an ordinary loss of ¥2.948 million; and net income attributable to owners of the parent was ¥82.149 million, compared with a quarterly net loss of ¥7.299 million.」

「Against this backdrop, the Group worked to expand orders in its advanced research and development support business, formerly called the metabolomics business, by conducting energetic sales activities using the Web, while also working to improve sales efficiency and reduce general and administrative expenses.」

「The Company achieved substantial cost reductions in selling, general and administrative expenses by promoting efficient sales activities, optimizing staff allocation, cancelling the planned new issuance of stock options, reducing expenses through a review of joint development activities, and other measures.」

「Against this backdrop, the Group sought to expand orders in the metabolomics business through vigorous sales activities using the web, while also working to improve sales efficiency and reduce general and administrative expenses. However, during the third quarter consolidated accounting period, both orders and sales declined because scheduled orders were postponed and measurement samples were delayed, resulting in lower revenue for the third quarter cumulative consolidated period as well.」

「Against this backdrop, the Group worked to expand orders in the metabolomics business by actively conducting web-based sales activities, while also pursuing improvements in sales efficiency and reductions in general and administrative expenses. In addition, through reductions in general and administrative expenses and other measures, the Company recorded operating income of ¥2.358 million for the first time for a second-quarter cumulative period, compared with an operating loss of ¥123.179 million in the same period of the previous year.」

「Against this backdrop, the Group worked to expand orders in its metabolomics business by conducting energetic sales activities using the Web, while also working to improve sales efficiency and reduce general and administrative expenses.」

「The Company achieved substantial cost reductions in selling, general and administrative expenses by promoting efficient sales activities and optimizing staff allocation in the metabolomics business, among other measures.」